BioStem Technologies, Inc.
BSEM
$14.69
$0.1621.12%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 216.48% | 148.46% | 65.86% | -48.96% | -- |
| Total Depreciation and Amortization | 11.37% | -9.58% | 5.98% | 2.88% | -- |
| Total Amortization of Deferred Charges | 641.26% | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.02% | 52.49% | 45.09% | 0.69% | -- |
| Change in Net Operating Assets | -3,701.58% | -1,546.61% | -1,010.41% | -183.19% | -- |
| Cash from Operations | 691.77% | 306.85% | -136.41% | -1,248.68% | -- |
| Capital Expenditure | -97.59% | -293.41% | 69.02% | 56.77% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 53.52% | 53.52% | 53.52% | 53.52% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,310.36% | 123.88% | 200.00% | -- | -- |
| Cash from Investing | -450.48% | -8.70% | 88.87% | 55.20% | -- |
| Total Debt Issued | -97.37% | -69.98% | 47.97% | 48.15% | -- |
| Total Debt Repaid | -34.38% | -120.33% | -125.64% | -52.88% | -- |
| Issuance of Common Stock | 414.06% | 431.96% | 830.58% | 4,659.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -38.81% | -11.19% | 245.63% | 429.46% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,656.85% | 695.98% | 174.86% | -223.39% | -- |